OncoSec Medical Inc (ONCSQ)

[InTheTrenches]

hschlauch:

This is the reason I really like ONCS as a long-term investment. With the recently reported results (41% CR in R/R melanoma, better than results with other drugs), and a good opportunity with multigene constructs to significantly improve on that, there is a real possibility for ONCS drugs to become one of the premier treatments in melanoma.

Further, achieving similar results in trials in other cancers would transform ONCS from a niche player to a platform.